2397. Clostridium difficile Infection: Update on Therapeutics and FMT
Session: Mini-Symposium: Diagnostic and Therapeutic Challenges in Clostridium difficile Infection
Sunday, October 30, 2016: 8:30 AM
Room: 391-392
Elizabeth Hohmann, MD, FIDSA, Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA


Disclosures:

E. Hohmann, Seres Therapeutics: Consultant and Grant Investigator , Consulting fee and Research support

See more of: Diagnostic and Therapeutic Challenges in Clostridium difficile Infection
See more of: Mini-Symposium
<< Previous Abstract | Next Abstract

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.